OVERACTIVE BLADDER
Abstract
In recent years, there has been a steady increase in patients visiting a specialist for what is known as overactive bladder syndrome. Due to the extremely negative impact of the disease on patients' quality of life, timely diagnosis and adequate treatment choices are of the utmost importance. The guidelines presented include a description of the etiology and pathogenesis, basic principles of diagnosis, and current methods of treatment for this category of patients.
References
Hubchev G., "Surgical tactitis in women with pelvic organ prolapse and latent stress incontinence"; Thesis 2017, pp. 25-31
Hubchev G., “Contemporary surgical treatment of stress incontinence in women”; Obstetrics and Gynecology, Book 5/2017, p. 62
Hubchev G., "Overactive bladder"; Scientific Work - Studios 2020, p.27
Ahlberg J., Edlund C., Wikkelso C. et al. Neurological signs are common in patients with urodynamically verified «idiopathic» bladder overactivity // Neurourol. Urodyn. - 2002. - Vol. 21. - N 1. - P. 65-70.
Gormley E.A., Lightner D.J., Faraday M., Vasavada S.P., American Urological Association, Society of Urodynamics et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment // J. Urol. - 2015. - May. - Vol. 193. - N 5. - P. 1572-1580.
Damiano R., Cicione A.The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease // The Adv. Urol. - 2011. - Vol. 3. - N 5. - P. 223-232.
Stewart W.F., Van Rooyen J.B., Cundiff G.W., Abrams P., Herzog A.R., Corey R. et al. Prevalence and burden of overactive bladder in the United States // World J. Urol. - 2003. - May. - Vol. 20. - N 6. - P. 327-336.
Siracusano S., Cucchi S., Ciciliato S, Lampropoulou N, Vittur F. Urinary levels of giycosaminoglycans in patients with idiopathic detrusor overactivity // Int. Urogynecol. J. Pelvic. Floor. Dysfunct. - 2009. - Dec. - Vol. 20. - N 12. - P. 1477-1480.
Vij M., Drake M.J. Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome // Ther. Adv. Urol. - 2015. - Oct. - Vol. 7. - N 5. - P. 241-248.
Wein A.J., Rovner E.S. Definition and epidemiology of overactive bladder // Urology. - 2002. - Nov. - Vol. 60. - N 5. - Suppl. 1. - P. 7-12. - Discussion 12.
Zhang W., Song Y., He X. et al. Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women // Neurourol. Urodyn. - 2006. - Vol. 25. - N 7. - P. 717-721.
Views:
237
Downloads:
168
Copyright (c) 2020 The authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
